# Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma (RCC) Patients

> **NCT01182142** · PHASE2 · COMPLETED · sponsor: **Kidney Cancer Research Bureau** · enrollment: 51 (estimated)

## Conditions studied

- Metastatic Renal Cell Carcinoma

## Interventions

- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT01182142
- **Lead sponsor:** Kidney Cancer Research Bureau
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-09
- **Final completion:** 2010-08
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2010-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01182142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01182142, "Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma (RCC) Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01182142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*